Cargando…

Rational immunogen design to target specific germline B cell receptors

Detalles Bibliográficos
Autores principales:	Jardine, J, Kalyuzhniy, O, Ota, T, McGuire, A, Menis, S, Julien, J, Falkowska, E, MacPherson, S, Jones, M, Burton, DR, Wilson, IA, Stamatatos, L, Nemazee, D, Schief, WR
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441540/ http://dx.doi.org/10.1186/1742-4690-9-S2-O71

Ejemplares similares

Engineered mice and B cell lines expressing broadly neutralizing antibodies and their unmutated precursors: tools for HIV vaccinology
por: Nemazee, D, et al.
Publicado: (2012)

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
por: McGuire, Andrew T., et al.
Publicado: (2013)

Structural basis for germline antibody recognition of HIV-1 immunogens
por: Scharf, Louise, et al.
Publicado: (2016)

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
por: Carrico, CT, et al.
Publicado: (2009)

Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
por: Briney, Bryan, et al.
Publicado: (2016)

Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
por: Seydoux, Emilie, et al.
Publicado: (2021)

Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
por: Hoot, Sam, et al.
Publicado: (2013)

Analyzing genomes: is there a duty to disclose?
por: McGuire, Amy
Publicado: (2012)

Correction: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
por: Hoot, Sam, et al.
Publicado: (2013)

Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
por: McGuire, Andrew T., et al.
Publicado: (2016)

P05-09. 4e10 epitope-scaffolds mimic the antibody-bound epitope conformation and block neutralization by sera from rare HIV+ individuals
por: Ban, YA, et al.
Publicado: (2009)

Germline epigenetics, and reprogramming in zebrafish early embryos
por: Potok, Magdalena E, et al.
Publicado: (2013)

HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
por: Steichen, Jon M., et al.
Publicado: (2016)

Rational use of SARS-CoV-2 polymerase chain reaction tests within institutions caring for the vulnerable
por: Yates, Tom A., et al.
Publicado: (2020)

In silico polypharmacology: retrospective recognition vs. rational design
por: Proschak, Ewgenij
Publicado: (2014)

29. Sustained Recovery in Patients Admitted to Hospital With COVID-19
por: Moestrup, Kasper S, et al.
Publicado: (2021)

Host response to tuberculosis as basis for rational design of vaccines and biomarkers
por: Kaufmann, Stefan HE
Publicado: (2010)

OA03.01. Acupuncture for chronic pain: an individual patient data meta-analysis of randomized trials
por: Vickers, A, et al.
Publicado: (2012)

Prediction of B-cell epitopes – "Step 1" for rational vaccine design
por: Gershoni, Jonathan M
Publicado: (2006)

Rational engineering of Fc/Fc receptor interactions to improve antibody potency
por: Doberstein, S, et al.
Publicado: (2003)

Protein engineering strategies for rational immunogen design
por: Caradonna, Timothy M., et al.
Publicado: (2021)

S107: IDENTIFICATION AND CHARACTERIZATION OF GERMLINE NBN VARIANTS RELATED TO B-ALL PREDISPOSITION
por: Escherich, Carolin, et al.
Publicado: (2023)

Improving the immunogenicity of HIV-1 envelope trimer vaccines
por: Sanders, Rogier W
Publicado: (2011)

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
por: Miller, WR
Publicado: (2006)

Full-length HIV-1 immunogens induce greater T lymphocyte responses to conserved epitopes than conserved-region-only HIV-1 immunogens in monkeys
por: Stephenson, KE, et al.
Publicado: (2012)

Case report: a giant cell-rich gnathic bone lesion in a child with pycnodysostosis
por: Spencer, C., et al.
Publicado: (2023)

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses
por: Hoffenberg, S, et al.
Publicado: (2012)

4. Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Adults
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma
por: Colombino, Maria, et al.
Publicado: (2014)

Vancomycin-specific T Cell responses in allergic and non-allergic individuals
por: Polak, Marta E, et al.
Publicado: (2014)

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases
por: Heijstek, MW, et al.
Publicado: (2011)

OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS
por: Di Grazia, A., et al.
Publicado: (2021)

The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer
por: Sharon, Shay, et al.
Publicado: (2023)

Germline mutations in DNA repair and cell cycle checkpoint genes: consequential somatic gene alterations and genome instability
por: Ingvarsson, S
Publicado: (2003)

MAb PGT121 protects against mucosal SHIV challenge in macaques at concentrations corresponding to its highly potent in vitro neutralization capacity
por: Moldt, B, et al.
Publicado: (2012)

P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens
por: Ching, LK, et al.
Publicado: (2009)

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
por: Hirao, Lauren, et al.
Publicado: (2006)

Development of a hypoallergenic and immunogenic Pru p 3 proline variant for treatment of peach allergy
por: Eichhorn, Stephanie, et al.
Publicado: (2014)

Engineered immunogen binding to alum adjuvant enhances humoral immunity
por: Moyer, Tyson J., et al.
Publicado: (2020)

Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice
por: Melzi, Eleonora, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_suhuj3l1cmtl3vamjuh45rdhis